Patient population and unmet treatment needs in osteoarthritis of the knee
First written in FY2021-Q2. 6 of 8 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024RestatedAnnual report
「The potential patient population in Japan is estimated at approximately 25 million, of whom approximately 10 million are estimated to have symptoms.」
The patient population for knee osteoarthritis and the need for new treatments that promote cartilage repair have been reaffirmed. - FY2024-Q3RestatedAnnual report
「Knee osteoarthritis is a disease in which wear of the knee cartilage deforms the shape of the knee, causing pain and swelling. In severe cases, the intense pain often makes walking difficult, with marked declines in QOL and activities of daily living. The potential patient population in Japan is estimated at approximately 25 million, of whom approximately 10 million are estimated to have symptoms.」
The estimates of approximately 25 million knee osteoarthritis patients and approximately 10 million patients with symptoms, together with the treatment need, have been reaffirmed. - FY2024-Q1RestatedAnnual report
「Knee osteoarthritis is a disease in which wear of the knee cartilage deforms the shape of the knee, causing pain and swelling. In severe cases, the intense pain often makes walking difficult, with marked declines in QOL and activities of daily living. The potential patient population in Japan is estimated at approximately 25 million, of whom approximately 10 million are estimated to have symptoms.」
The estimates of approximately 25 million knee osteoarthritis patients and approximately 10 million patients with symptoms, together with the treatment need, have been reaffirmed. - FY2023-Q1RestatedAnnual report
「The potential patient population in Japan is estimated at approximately 25 million, of whom approximately 10 million are estimated to have symptoms. Aging is the primary cause, and the disease commonly develops in middle-aged and older people in their 40s and beyond. Damaged articular cartilage is known to have limited capacity for self-repair, creating a need for new treatments that promote repair of damaged cartilage tissue or avoid progression to artificial joint replacement surgery.」
The patient population for knee osteoarthritis and the need for new treatments that promote cartilage repair have been reaffirmed. - FY2022Upward revision to the estimated patient populationAnnual report
「The potential patient population in Japan is estimated at approximately 25 million, of whom approximately 10 million are estimated to have symptoms.」
The estimate of knee osteoarthritis patients with symptoms has changed from approximately 8 million to approximately 10 million. - FY2022-Q1RestatedAnnual report
「The potential patient population in Japan is estimated at approximately 25 million, of whom approximately 8 million are estimated to have symptoms. Aging is the primary cause, and the disease commonly develops in middle-aged and older people in their 40s and beyond. Damaged articular cartilage is known to have limited capacity for self-repair, creating a need for new treatments that promote repair of damaged cartilage tissue or avoid progression to artificial joint replacement surgery.」
The patient population for knee osteoarthritis and the need for new treatments that promote cartilage repair have been reaffirmed. - FY2021-Q3RestatedAnnual report
「Knee osteoarthritis is a disease in which wear of the knee cartilage deforms the shape of the knee, causing pain and swelling. In severe cases, the intense pain often makes walking difficult, with marked declines in quality of life (QOL) and activities of daily living. The potential patient population in Japan is estimated at approximately 25 million, of whom approximately 8 million are estimated to have symptoms. Aging is the primary cause, and the disease commonly develops in middle-aged and older people in their 40s and beyond. Damaged articular cartilage is known to have limited capacity for self-repair, creating a need for new treatments that promote repair of damaged cartilage tissue or avoid progression to artificial joint replacement surgery.」
The patient population for knee osteoarthritis and the need for new treatments that promote cartilage repair have been reiterated. - FY2021-Q2First statedAnnual report
「Knee osteoarthritis is a disease in which wear of the knee cartilage deforms the shape of the knee, causing pain and swelling. In severe cases, the intense pain often makes walking difficult, with marked declines in quality of life (QOL) and activities of daily living. The potential patient population in Japan is estimated at approximately 25 million, of whom approximately 8 million are estimated to have symptoms. Aging is the primary cause, and the disease commonly develops in middle-aged and older people in their 40s and beyond. Damaged articular cartilage is known to have limited capacity for self-repair, creating a need for new treatments that promote repair of damaged cartilage tissue or avoid progression to artificial joint replacement surgery.」
For knee osteoarthritis, estimates of approximately 25 million potential patients and approximately 8 million patients with symptoms, together with the need for new treatments against the backdrop of cartilage's limited capacity for self-repair, have been presented.